{"description":["Click here to enter Description"],"effective_time":"20140417","id":"7b0b8384-bed3-4a48-905f-92b39439186f","openfda":{},"package_label_principal_display_panel":["PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Irbesartan and Hydrochlorothiazide 150-12.5 mg","PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Irbesartan and Hydrochlorothiazide 300/12.5 mg"],"set_id":"faf066dc-3e66-48bf-9c90-f18dce0df1e5","spl_medguide":["[Enter Medication Guide here]"],"spl_product_data_elements":["Irbesartan and Hydrochlorothiazide Irbesartan and Hydrochlorothiazide IRBESARTAN IRBESARTAN HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE CROSCARMELLOSE SODIUM FERRIC OXIDE RED FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE LECITHIN, SOYBEAN MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 3350 POLYVINYL ALCOHOL, UNSPECIFIED TALC TITANIUM DIOXIDE 325;HH Irbesartan and Hydrochlorothiazide Irbesartan and Hydrochlorothiazide IRBESARTAN IRBESARTAN HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE CROSCARMELLOSE SODIUM FERRIC OXIDE RED FERRIC OXIDE YELLOW FERROSOFERRIC OXIDE HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE LECITHIN, SOYBEAN MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 3350 POLYVINYL ALCOHOL, UNSPECIFIED TALC TITANIUM DIOXIDE 327;HH"],"version":"2"}